Evaluation of tumor response to immune checkpoint inhibitors by a 3D immunotumoroid model.

Saved in:
Bibliographic Details
Title: Evaluation of tumor response to immune checkpoint inhibitors by a 3D immunotumoroid model.
Authors: Pezeshki A; Biomarker Discovery, Mayo Clinic, Rochester, MN, United States.; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, United States., Cheville JC; Biomarker Discovery, Mayo Clinic, Rochester, MN, United States.; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States., Florio AB; Biomarker Discovery, Mayo Clinic, Rochester, MN, United States.; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, United States., Leibovich BC; Urology, Mayo Clinic, Rochester, MN, United States., Vasmatzis G; Biomarker Discovery, Mayo Clinic, Rochester, MN, United States.; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, United States.
Source: Frontiers in immunology [Front Immunol] 2024 Mar 28; Vol. 15, pp. 1356144. Date of Electronic Publication: 2024 Mar 28 (Print Publication: 2024).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first